Buy or sell Mevion Medical Systems stock pre IPO via an EquityZen fund
Mevion Medical Systems Stock
Mevion Medical Systems develops radiation therapies for the treatment of cancer.
About Mevion Medical Systems Stock
Mevion Medical Systems, Inc. (formerly Still River Systems, Inc.) is a radiation therapy company dedicated to advancing the treatment of cancer. As the pioneering developer of modern proton therapy systems, Mevion provides innovative, safe, and effective solutions by transforming advances in medical technology and science into practical clinical reality. Mevion’s flagship product, the MEVION S250 Proton Therapy System, is designed to preserve all of the treatment benefits of traditional proton therapy systems while removing the obstacles of size, cost, and complexity. Realizing this vision, Mevion has forever changed the economics and accessibility of proton therapy worldwide. Founded in 2004, Mevion is a privately held company headquartered in the Boston metropolitan area with international offices in the United Kingdom and Japan.
Vice President of Regulatory and Quality Assurance
Vice President of Engineering
Vice President Clinical Systems
President and Chief Executive Officer
Joseph K. Jachinowski
Chief Executive Officer
Tina Tianning Yu